Enriched cancer pathway | Genes under regulation | P value |
PI3K AKT signaling pathway |
11 genes: FGF5, MAPK1, LAMC3, TNC, ITGB3, GNB5, PTEN, PPP2CB, PPP2R2A, PHLPP2, CDK6
|
3.072e-05 |
Hippo signaling pathway |
6 genes: WTIP, PPP2CB, PPP2R2A, TEAD1, SMAD4, SERPINE1
|
0.0006783 |
p53 signaling pathway |
4 genes: CDK6, SERPINE1, PTEN, ZMAT3
|
0.001291 |
Long.term depression |
4 genes: GRIA3, ITPR1, PPP2CB, MAPK1
|
0.001362 |
Phosphatidylinositol signaling system |
4 genes: DGKG, ITPR1, PIP4K2A, PTEN
|
0.002031 |
ECM.receptor interaction |
4 genes: LAMC3, TNC, ITGB3, CD47
|
0.002779 |
Regulation of actin cytoskeleton |
6 genes: WASF2, CFL2, FGF5, ITGB3, PIP4K2A, MAPK1
|
0.003601 |
Fc gamma R.mediated phagocytosis |
4 genes: WASF2, CFL2, AMPH, MAPK1
|
0.004145 |
Focal adhesion |
5 genes: LAMC3, TNC, ITGB3, MAPK1, PTEN
|
0.01229 |
Adherens junction |
3 genes: WASF2, SMAD4, MAPK1
|
0.0138 |
TGF.beta signaling pathway |
3 genes: SMAD4, PPP2CB, MAPK1
|
0.02065 |
MAPK signaling pathway |
5 genes: FGF5, MEF2C, MAPK1, TAOK1, PTPN7
|
0.0374 |
Oocyte meiosis |
3 genes: ITPR1, PPP2CB, MAPK1
|
0.04364 |
mTOR signaling pathway |
2 genes: CAB39, MAPK1
|
0.04944 |